As of 2025-05-25, the Gross Margin of Oncology Pharma Inc (ONPH) is 44.6%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2013-03-31 | 44.6% |
2011-09-30 | - |
2011-06-30 | 25.4% |
2004-03-31 | 44.6% |
2003-03-31 | 63.1% |
2002-03-31 | 63% |
2001-03-31 | 60.4% |
2000-03-31 | 27.3% |
1999-03-31 | 37.8% |
1998-06-30 | 30.3% |